Application of nanotechnology in the diagnosis and therapy of melanoma

Abstract

Tang Jianqin, Hou Xiaoyang, Jiang Guan, Wei Zhiping, Liu Yanqun. Application of nanotechnology in the diagnosis and therapy of melanoma[J]. Journal of International Oncology, 2016, 43(11): 871-873.

［1］ Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014［J］. CA Cancer J Clin, 2014, 64(1): 9-29. DOI: 10.3322/caac. ［2］ Chung C, Reilly S. Trametinib: a novel signal transduction inhibitor for the treatment of metastatic cutaneous melanoma［J］. Am J Health Syst Pharm, 2015, 72(2): 101-110. DOI: 10.2146/ajhp140045. ［3］ Luke JJ, Hodi FS. Ipilimumab, vemurafenib, dabrafenib, and trametinib: synergistic competitors in the clinical management of BRAF mutant malignant melanoma［J］. Oncologist, 2013, 18(6): 717-725. DOI: 10.1634/theoncologist. ［4］ Bamrungsap S, Zhao Z, Chen T, et al. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system［J］. Nanomedicine (Lond), 2012, 7(8): 1253-1271. DOI: 10.2217/nnm. ［5］ Kumari P, Ghosh B, Biswas S. Nanocarriers for cancertargeted drug delivery［J］. J Drug Target, 2016 , 24(3): 179-191. DOI: 10.3109/1061186X. ［6］ AhlgrimmSiess V, Laimer M, Arzberger E, et al. New diagnostics for melanoma detection: from artificial intelligence to RNA microarrays［J］. Future Oncol, 2012, 8(7): 819-827. DOI: 10.2217/fon. ［7］ Flaherty KT. Targeting metastatic melanoma［J］. An Rev Med, 2012, 63: 171-183. DOI: 10.1146/annurev-med-050410-105655. ［8］ Ong FS, Das K, Wang J, et al. Personalized medicine and pharmacogenetic biomarkers: progress in molecular oncology testing［J］. Expert Rev Mol Diagn, 2012, 12(6): 593-602. DOI: 10.1586/erm.12.59. ［9］ Huber F, Lang HP, Backmann N, et al. Direct detection of a BRAF mutation in total RNA from melanoma cells using cantilever arrays［J］. Nat Nanotechnol, 2013, 8(2): 125-129. DOI: 10.1038/nnano.2012.263. ［10］ Kim MJ, Lee JY, Nehrbass U, et al. Detection of melanoma using antibodyconjugated quantum dots in a coculture model for highthroughput screening system［J］. Analyst, 2012, 137(6): 1440-1445. DOI: 10.1039/c2an16013g. ［11］ Li Z, Huang P, Lin J, et al. Arginineglycineaspartic acidconjugated dendrimermodified quantum dots for targeting and imaging melanoma［J］. J Nanosci Nanotechnol, 2010, 10(8): 48594867. DOI: 10.1166/jnn.2010.2217. ［12］ Vannucci L, Falvo E, Failla CM, et al. In vivo targeting of cutaneous melanoma using an melanoma stimulating hormoneengineered human protein cage with fluorophore and magnetic resonance imaging tracers［J］. J Biomed Nanotechnol, 2015, 11(1): 8192. DOI: 10.1186/1479587612S1P6. ［13］ Bei D, Meng J, Youan BB. Engineering nanomedicines for improved melanoma therapy: progress and promises［J］. Nanomedicine (Lond), 2010, 5(9): 1385-1399. DOI: 10.2217/nnm. ［14］ Wang AZ, Langer R, Farokhzad OC. Nanoparticle delivery of cancer drugs［J］. Annu Rev Med, 2012, 63: 185198. DOI: 10.1146/annurevmed040210162544. ［15］ Christian DA, Cai S, Bowen DM, et al. Polymersome carriers: from selfassembly to siRNA and protein therapeutics［J］. Eur J Pharm Biopharm, 2009, 71(3): 463-474. DOI: 10.1016/j.ejpb.2008.09.025. ［16］ Bonifácio BV, Silva PB, Ramos MA, et al. Nanotechnologybased drug delivery systems and herbal medicines: a review［J］. Int J Nanomedicine, 2014, 9: 1-15. DOI: 10.2147/IJN.S52634. ［17］ Pegoraro C, Cecchin D, Gracia LS, et al. Enhanced drug delivery to melanoma cells using PMPCPDPA polymersomes［J］. Cancer Lett, 2013, 334(2): 328337. DOI: 10.1016/j.canlet.2013.02.007. ［18］ Anilkumar P, Lu F, Cao L, et al. Fullerenes for applications in biology and medicine［J］. Curr Med Chem, 2011, 18(14): 2045-2059. DOI: 10.2174/092986711795656225. ［19］ Chaudhuri P, Soni S, Sengupta S. Singlewalled carbon nanotubeconjugated chemotherapy exhibits increased therapeutic index in melanoma［J］. Nanotechnology, 2010, 21(2): 025102. DOI: 10.1088/09574484/21/2/025102. ［20］ Wang Y, Mo L, Wei W, et al. Efficacy and safety of dendrimer nanoparticles with coexpression of tumor necrosis factoralpha and herpes simplex virus thymidine kinase in gene radiotherapy of the human uveal melanoma OCM1 cell line［J］. Int J Nanomedicine, 2013, 8: 38053816. DOI: 10.2147/IJN.S48950. ［21］ Siu KS, Chen D, Zheng X, et al. Noncovalently functionalized singlewalled carbon nanotube for topical siRNA delivery into melanoma［J］. Biomaterials, 2014, 35(10): 3435-3442. DOI: 10.1016/j.biomaterials.2013.12.079. ［22］ Scodeller P, Catalano PN, Salguero N, et al. Hyaluronan degrading silica nanoparticles for skin cancer therapy［J］. Nanoscale, 2013, 5(20): 9690-9698. DOI: 10.1016/j.biomaterials.2013.12.079. ［23］ Choi BB, Kim MS, Kim UK, et al. Targeting NEU protein in melanoma cells with nonthermal atmospheric pressure plasma and gold nanoparticles［J］. J Biomed Nanotechnol, 2015, 11(5): 900-905. DOI: 10.1166/jbn.2015.1999. ［24］ Yao H, Ng SS, Huo LF, et al. Effective melanoma immunotherapy with interleukin2 delivered by a novel polymeric nanoparticle［J］. Mol Cancer Ther, 2011, 10(6): 1082-1092. DOI: 10.1158/1535-7163.MCT-10-0717. ［25］ Tan S, Sasada T, Bershteyn A, et al. Combinational delivery of lipidenveloped polymeric nanoparticles carrying different peptides for antitumor immunotherapy［J］. Nanomedicine (Lond), 2014, 9(5): 635-647. DOI: 10.2217/NNM.13.67 ［26］ Camerin M, Magaraggia M, Soncin M, et al. The in vivo efficacy of phthalocyanine nanoparticle conjugates for the photodynamic therapy of amelanotic melanoma［J］. Eur J Cancer, 2010, 46(10): 19101918. DOI: 10.1016/j.ejca.2010.02.037. ［27］ Idris NM, Gnanasammandhan MK, Zhang J, et al. In vivo photodynamic therapy using upconversion nanoparticles as remotecontrolled nanotransducers［J］. Nat Med, 2012, 18(10): 1580-1585. DOI: 10.1038/nm.2933. ［28］ LeonFerre RA, Markovic SN. Nabpaclitaxel in patients with metastatic melanoma［J］. Expert Rev Anticancer Ther, 2015, 15(12): 1371-1377. DOI: 10.1586/14737140.2015.1110024.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yuan Jian, Huang Yanhua.Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer[J]. Journal of International Oncology, 2024, 51(6): 338-343.
[3]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi.Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer[J]. Journal of International Oncology, 2024, 51(5): 286-291.
[4]	Chen Qi, Xu Chenyang, Wang Yin, Lei Dapeng.Current application status of hyperspectral imaging in the diagnosis and treatment of head and neck tumor[J]. Journal of International Oncology, 2024, 51(5): 298-302.
[5]	Zhang Lili, Tan Ru, Fang Xueli, Yang Yu, Sang Zheng, Li Baosheng.Imaging diagnosis， pathological upgrade， and imaging technology progress of ductal carcinomain situof the breast[J]. Journal of International Oncology, 2024, 51(3): 166-169.
[6]	Peng Qin, Cai Yuting, Wang Wei.Advances on KPNA2 in liver cancer[J]. Journal of International Oncology, 2024, 51(3): 181-185.
[7]	Jin Xudong, Chen Zhongjian, Mao Weimin.Research progress on the role of MTAP in malignant mesothelioma[J]. Journal of International Oncology, 2024, 51(2): 99-104.
[8]	Huang Zhen, Chen Yongshun.Research progress of circulating tumor DNA in the diagnosis and treatment of hepatocellular carcinoma[J]. Journal of International Oncology, 2024, 51(1): 59-64.
[9]	Wang Jing, Xu Wenting.Value of NLR， CEA combined with coagulation indicators in the differential diagnosis of benign and malignant breast nodules with a diameter ≤ 1.0 cm[J]. Journal of International Oncology, 2023, 50(9): 520-526.
[10]	Shandong Medical Association Multidisciplinary Joint Committee on Lung Cancer.Shandong Provincial Medical Association multidisciplinary standardized diagnosis and treatment guidelines for esophageal carcinoma （2023 Edition）[J]. Journal of International Oncology, 2023, 50(7): 385-397.
[11]	Wu Minhang, Sun Wenzheng, Yu Qingzhuo, Guo Rong, Ye Hui, Du Ying, Qiu Jin, An Huazhang, Cao Lili.RNF43 inhibits PD-L1 expressionviaβ-catenin in melanoma cells and promotes CD8⁺T cell-mediated anti-tumor immune reaction[J]. Journal of International Oncology, 2023, 50(7): 407-412.
[12]	Ju Yifan, Xu Chenyang, Lei Dapeng.Research progress of pathomics in head and neck neoplasms[J]. Journal of International Oncology, 2023, 50(5): 294-298.
[13]	Xiong Min, Chen Yi, Wang Jianbo.Value of CT radiomic features in differential diagnosis of lung metastases[J]. Journal of International Oncology, 2023, 50(4): 208-213.
[14]	Qian Weiwei, Xu Shen, Kong Qi.Differential diagnosis value of D-dimer before operation in renal oncocytoma and chromophobe renal cell carcinoma[J]. Journal of International Oncology, 2023, 50(10): 614-617.
[15]	Wang Yixin, Cao Meng, Wang Yan.Application progress of domestic carbon nanoparticles suspension in sentinel lymph node biopsy for malignant tumors[J]. Journal of International Oncology, 2023, 50(1): 22-27.

Application of nanotechnology in the diagnosis and therapy of melanoma

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments